266 related articles for article (PubMed ID: 29987915)
21. Use of atypical antipsychotics and risks of cataract development in patients with schizophrenia: A population-based, nested case-control study.
Chou PH; Chu CS; Lin CH; Cheng C; Chen YH; Lan TH; Huang MW
Schizophr Res; 2016 Jul; 174(1-3):137-143. PubMed ID: 27061658
[TBL] [Abstract][Full Text] [Related]
22. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
Jiménez-Cornejo M; Munizaga G; Aceituno D
Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
[TBL] [Abstract][Full Text] [Related]
23. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
24. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
[TBL] [Abstract][Full Text] [Related]
25. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
Leslie DL; Rosenheck RA
Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
[TBL] [Abstract][Full Text] [Related]
26. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
[TBL] [Abstract][Full Text] [Related]
27. Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case-control study.
Wu CS; Chang CM; Tsai YT; Huang YW; Tsai HJ
J Clin Psychiatry; 2015 Sep; 76(9):1216-23. PubMed ID: 26115407
[TBL] [Abstract][Full Text] [Related]
28. Clozapine induced akathisia: a case report and review of the evidence.
Grover S; Sahoo S
Indian J Pharmacol; 2015; 47(2):234-5. PubMed ID: 25878393
[TBL] [Abstract][Full Text] [Related]
29. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
30. Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients: a nested case-control study.
Hsieh PH; Hsiao FY; Gau SS; Gau CS
J Clin Psychopharmacol; 2013 Jun; 33(3):299-305. PubMed ID: 23609396
[TBL] [Abstract][Full Text] [Related]
31. Clozapine protects bone mineral density in female patients with schizophrenia.
Lin CH; Huang KH; Chang YC; Huang YC; Hsu WC; Lin CY; Huang-Chih Chou F; Tsai GE; Lane HY
Int J Neuropsychopharmacol; 2012 Aug; 15(7):897-906. PubMed ID: 22014454
[TBL] [Abstract][Full Text] [Related]
32. Antipsychotic medications and stroke in schizophrenia: A case-crossover study.
Chen WY; Chen LY; Liu HC; Wu CS; Yang SY; Pan CH; Tsai SY; Chen CC; Kuo CJ
PLoS One; 2017; 12(6):e0179424. PubMed ID: 28614417
[TBL] [Abstract][Full Text] [Related]
33. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
[TBL] [Abstract][Full Text] [Related]
34. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R
J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
[TBL] [Abstract][Full Text] [Related]
35. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815
[TBL] [Abstract][Full Text] [Related]
36. Antipsychotic medications and dental caries in newly diagnosed schizophrenia: A nationwide cohort study.
Hu KF; Chou YH; Wen YH; Hsieh KP; Tsai JH; Yang P; Yang YH; Lin CR
Psychiatry Res; 2016 Nov; 245():45-50. PubMed ID: 27526316
[TBL] [Abstract][Full Text] [Related]
37. Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
Citrome L; Jaffe A; Levine J; Allingham B; Robinson J
Psychiatr Serv; 2004 Sep; 55(9):1006-13. PubMed ID: 15345760
[TBL] [Abstract][Full Text] [Related]
38. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.
Ittasakul P; Archer A; Kezman J; Atsariyasing W; Goldman MB
Clin Schizophr Relat Psychoses; 2016; 10(2):120-2. PubMed ID: 27440213
[TBL] [Abstract][Full Text] [Related]
39. The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia.
Hofer A; Hummer M; Kemmler G; Kurz M; Kurzthaler I; Fleischhacker WW
Int J Neuropsychopharmacol; 2003 Sep; 6(3):201-6. PubMed ID: 12974985
[TBL] [Abstract][Full Text] [Related]
40. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]